In the News
Explore our featured articles, press highlights, and latest media coverage.
AS SEEN IN
In The News
Northwestern Medicine News Center
Dr. Kushner is named to the 2025 "Highly Cited Researchers" list, published by Clarivate Analytics, identifying investigators who have demonstrated significant influence in their field over previous 11 years
NPR
Dr. Kushner is interviewed about the new recommendations to move beyond BMI when diagnosing obesity
ABC News
Dr. Kushner is interviewed about the Lancet Commission's new report on redefining obesity
New York Post
Dr. Kushner is interviewed about new measurements for people with the disease of obesity
The Wall Street Journal
Dr. Kushner is interviewed about the pill versions of Ozempic-like drugs
businesswire
On behalf of the entire STEP 1 semaglutide study team, Dr. Kushner was proud to accept the Clinical Research Forum's 2022 top honors award for best clinical research study
Scientific American
Dr. Kushner discusses semaglutide and its implications for the treatment of obesity
FOX 32 Chicago
Sylvia Perez interviews Dr. Kushner about Six Factors to Fit: Weight Loss that Works for You!
The Washington Post
Dr. Kushner is interviewed about powerful new weight loss drugs that expose health inequities
The New York Times
As lead researcher for the semaglutide STEP 1 trial, Dr. Kushner discusses the unprecedented weight loss results
NBC News
Dr. Kushner weighs in on the obstacles people with obesity face getting medical care
In The News
Northwestern Medicine News Center
Dr. Kushner is named to the 2025 "Highly Cited Researchers" List, published by Clarivate Analytics, identifying investigators who have demonstrated significant influence in their field over the past 11 years
NPR
Dr. Kushner is interviewed about the new recommendations to move beyond BMI when diagnosing obesity
ABC News
Dr. Kushner is interviewed about the Lancet Commission's new report on redefining obesity
New York Post
Dr. Kushner is interviewed about new measurements for people with the disease of obesity
The Wall Street Journal
Dr. Kushner is interviewed about the pill versions of Ozempic-like drugs
Scientific American
Dr. Kushner discusses semaglutide and its implications for the treatment of obesity
businesswire
On behalf of the entire STEP 1 semaglutide study team, Dr. Kushner was proud to accept the Clinical Research Forum's 2022 top honors award for best clinical research study
NBC News
Dr. Kushner weighs in on the obstacles people with obesity face getting medical care
The New York Times
Dr. Kushner discusses how more powerful obesity fighting drugs may change perceptions of obesity as a disease
The New York Times
As the lead researcher for the semaglutide STEP 1 trial, Dr. Kushner discusses the unprecedented weight loss results
Fox 32 Chicago
Sylvia Perez interviews Dr. Kushner about Six Factors to Fit: Weight Loss that Works for You!
